- Cybin CYBN shares closed up 3.61% at $1.00
- Seelos Therapeutics SEEL shares closed down 8.33% at $1.21
- Mind Medicine MNMD shares closed down 5.13% at $0.79
- ATAI Life Sciences ATAI shares closed down 3.90% at $4.68
- Compass Pathways CMPS shares closed down 3.74% at $17.52
- Small Pharma DMTTF shares closed down 2.16% at $0.14
- Numinus Wellness NUMIF shares closed down 1.29% at $0.25
- GH Research GHRS shares closed down 1.19% at $14.96
- Revive Therapeutics RVVTF shares closed down 0.00% at $0.30
- Biomind Labs BMNDF shares closed down 0.00% at $0.77
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF